Please login to the form below

Not currently logged in
Email:
Password:

semaglutide

This page shows the latest semaglutide news and features for those working in and with pharma, biotech and healthcare.

Novo’s oral diabetes drug hits the mark again

Novo’s oral diabetes drug hits the mark again

Novo Nordisk’s much-anticipated orally formulated version of diabetes treatment Ozempic (semaglutide) has generated more positive data in a late stage trial, demonstrating its effectiveness at blood sugar reductions and ... in people with type 2

Latest news

More from news
Approximately 7 fully matching, plus 18 partially matching documents found.

Latest Intelligence

  • Oral biologics delivery still elusive Oral biologics delivery still elusive

    Novo Nordisk is also working with another specialist on oral delivery for protein drugs - Emisphere Technologies - that has applied its Eligen technology to develop an oral version of semaglutide, a

  • Deal Watch table for February 2014 Deal Watch table for February 2014

    Development. Semaglutide once weekly, ZP Patch Technology. 115. Andromeda / Teva Pharmaceutical Industries.

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Star

We're passionate about helping our clients to make a real commercial impact. We achieve this through our unique approach to...

Latest intelligence

Solaris Health looks at the gene therapy revolution
Gene therapies are bringing new hope for many people with diseases caused by genetic disorders...
PM Society Digital Awards – the power of together
Our chief executive, Emma Statham, writes about the value of awards and the power of together....
Seduction_feature_image_thumb.jpg
Seduce anyone in four simple steps
You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...

Infographics